Touch therapy calms nerves before breast biopsy, small study suggests
NCT ID NCT06056414
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a manual acupressure technique called Energy Resonance by Cutaneous Stimulation (RESC) to see if it could lower anxiety in 57 women about to undergo a breast macrobiopsy. Participants received a RESC session before the procedure, and their anxiety was measured using a standard questionnaire. The goal was to find a simple, non-drug way to help patients feel calmer during a stressful diagnostic procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Energy Resonance by Cutaneous Stimulation (manual acupressure technique)
- What this could lead to
- If it works, this could offer a non-drug way to ease anxiety before breast biopsies, making the experience less stressful for patients.
- What could go wrong
- This is a small, completed study with only 57 participants and no blinding, so results may not apply widely. The technique's effect may be due to placebo or patient expectations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
57 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient has received full information on the organization and purpose of the research, and has signed an informed consent form. * Patient over 18 years of age * Patient undergoing a diagnostic breast macrobiopsy for suspected breast cancer * Patient undergoing a macro breast biopsy for the first time * Patient affiliated to or benefiting from a social security schem Exclusion Criteria: * Patient with a history of breast cancer or other pathologies requiring invasive procedures * Patient with several lesions to be biopsied * Patient with psychiatric pathology * Patient under anxiolytic or psychotropic treatment initiated in the month before the breast macrobiopsy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Henri Becquerel
Rouen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill that blocks Cancer's 'Traffic Signals' stop advanced breast cancer?
- Can a simple letter boost breast cancer screening? singapore study aims to find out
- New scan could predict hormone therapy success in breast cancer
- New precision approach aims to wipe out breast cancer before surgery
- New program aims to help breast cancer survivors get back to work
- New combo vaccine and immunotherapy tackles Hard-to-Treat breast cancer